RFP-Human iPSC-Derived Endothelial Precursor Cells (iPSC-EPCs)
Quick Actions
Documentation 1 files
Product Overview
Description
Human iPSC-EPCs (Catalog # IPSCEP001) are highly pure, cryopreserved endothelial precursor cells derived from induced pluripotent stem cells (iPSCs) using a directed,
serum-free, GSK-3 and TGF- inhibitor-based differentiation protocol (CHIR99021 + SB431542). These cells represent an intermediate stage between mesodermal progenitors and mature endothelial cells, exhibiting robust proliferative capacity and the ability to differentiate into mature endothelial cells (arterial, venous, and lymphatic subtypes).
Source: Normal human iPSC line (fully characterized, pathogen-free, normal karyotype).
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: IPSCEP003
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Endothelial Precursor Markers
KDR: (VEGFR2, CD309) ,High positive(>90%) Receptor tyrosine kinase (membrane)
TIE2 :(CD202b) Positive Angiopoietin receptor
ETV2: (ER71) Positive (Nuclear),Master transcription
factor for endothelial specification
FLI1: Positive (Nuclear),ETS family transcription factor
Quick Facts
Product Type
iPSC-Derived
Viability
>90% viability post-thaw
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
